Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)
China · Delayed Price · Currency is CNY 4.130
-0.010 (-0.24%)
Apr 30, 2026, 3:04 PM CST
SHE:300194 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 62.35 | 76.49 | 279.84 | 231.87 | 204.61 | -296.91 |
Depreciation & Amortization | 205.27 | 205.27 | 198.26 | 209.07 | 184.43 | 174.29 |
Other Amortization | 1.26 | 1.26 | 0.96 | 0.72 | 0.97 | 0.7 |
Loss (Gain) From Sale of Assets | -0.27 | -0.27 | -0.01 | -220.65 | -4.85 | -0.31 |
Asset Writedown & Restructuring Costs | 154.1 | 154.1 | 37.77 | 228.06 | 25.41 | 827.23 |
Loss (Gain) From Sale of Investments | -138.55 | -138.55 | -77.37 | -77.8 | -62.16 | -52.47 |
Provision & Write-off of Bad Debts | - | - | 3.96 | -2.43 | 3.68 | 4.27 |
Other Operating Activities | 99.36 | 27.68 | 54.05 | 44.66 | 46.76 | -286.2 |
Change in Accounts Receivable | 77.95 | 77.95 | 46.84 | 71.85 | -78.5 | -68.26 |
Change in Inventory | 215.3 | 215.3 | -182.31 | 9.2 | -120.85 | -65.3 |
Change in Accounts Payable | -285.65 | -285.65 | -72.15 | -193.15 | 159.88 | 24.98 |
Change in Other Net Operating Assets | 0.73 | 0.73 | 10.07 | 4.8 | 4.4 | - |
Operating Cash Flow | 369.87 | 312.32 | 303.59 | 328.98 | 339.5 | 257.13 |
Operating Cash Flow Growth | 110.49% | 2.88% | -7.72% | -3.10% | 32.04% | 58.18% |
Capital Expenditures | -89.26 | -108.43 | -241.79 | -215.68 | -383.1 | -413.03 |
Sale of Property, Plant & Equipment | 0.48 | 5.91 | 0.3 | 122.67 | 4.28 | 31.49 |
Cash Acquisitions | - | - | - | - | - | -1 |
Divestitures | - | - | -4.63 | - | -0.06 | - |
Investment in Securities | -140 | -120 | -54.81 | -1.25 | -71.43 | 32.38 |
Other Investing Activities | -19.25 | -0.03 | 36.1 | 0.64 | 10.31 | 0.94 |
Investing Cash Flow | -248.03 | -222.56 | -264.83 | -93.62 | -440.01 | -349.24 |
Short-Term Debt Issued | - | - | 83.04 | - | 49.28 | - |
Long-Term Debt Issued | - | 1,052 | 485.09 | 848.08 | 588.56 | 964.75 |
Total Debt Issued | 427.1 | 1,052 | 568.13 | 848.08 | 637.84 | 964.75 |
Short-Term Debt Repaid | - | - | -37 | - | - | - |
Long-Term Debt Repaid | - | -971.15 | -666.25 | -706.06 | -802.42 | -683 |
Total Debt Repaid | -660.13 | -971.15 | -703.25 | -706.06 | -802.42 | -683 |
Net Debt Issued (Repaid) | -233.03 | 80.65 | -135.12 | 142.02 | -164.58 | 281.75 |
Common Dividends Paid | -103.8 | -104.99 | -84.22 | -93.98 | -28.09 | -84.11 |
Other Financing Activities | -12.64 | 14.39 | -8.59 | -1.78 | 20.99 | 13.77 |
Financing Cash Flow | -349.47 | -9.96 | -227.93 | 46.25 | -171.68 | 211.41 |
Foreign Exchange Rate Adjustments | -0.28 | 0.36 | 0.91 | 0.88 | 2.91 | -2.17 |
Net Cash Flow | -227.92 | 80.17 | -188.26 | 282.49 | -269.27 | 117.13 |
Free Cash Flow | 280.61 | 203.89 | 61.8 | 113.3 | -43.6 | -155.91 |
Free Cash Flow Growth | - | 229.94% | -45.46% | - | - | - |
Free Cash Flow Margin | 16.72% | 11.73% | 2.58% | 4.28% | -1.80% | -6.35% |
Free Cash Flow Per Share | 0.22 | 0.16 | 0.05 | 0.09 | -0.04 | -0.13 |
Cash Income Tax Paid | 144.62 | 136.58 | 202.61 | 198.28 | 155.41 | 190.43 |
Levered Free Cash Flow | 246.65 | 167.83 | -37.48 | 98.2 | -60.74 | -139.3 |
Unlevered Free Cash Flow | 246.65 | 167.83 | -22.89 | 116.68 | -43.91 | -126.52 |
Change in Working Capital | -13.65 | -13.65 | -193.86 | -84.51 | -59.35 | -113.48 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.